1
|
Argunhan F, Thapa D, Aubdool AA, Carlini E, Arkless K, Hendrikse ER, de Sousa Valente J, Kodji X, Barrett B, Ricciardi CA, Gnudi L, Hay DL, Brain SD. Calcitonin Gene-Related Peptide Protects Against Cardiovascular Dysfunction Independently of Nitric Oxide In Vivo. Hypertension 2021; 77:1178-1190. [PMID: 33641368 DOI: 10.1161/hypertensionaha.120.14851] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
[Figure: see text].
Collapse
Affiliation(s)
- Fulye Argunhan
- From the Section of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Excellence, King's College London, Franklin-Wilkins Building, Waterloo Campus, United Kingdom (F.A., D.T., E.C., K.A., J.d.S.V., X.K., B.B., C.A.R., L.G., S.D.B.)
| | - Dibesh Thapa
- From the Section of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Excellence, King's College London, Franklin-Wilkins Building, Waterloo Campus, United Kingdom (F.A., D.T., E.C., K.A., J.d.S.V., X.K., B.B., C.A.R., L.G., S.D.B.)
| | - Aisah Aniisah Aubdool
- William Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, United Kingdom (A.A.A.)
| | - Emanuele Carlini
- From the Section of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Excellence, King's College London, Franklin-Wilkins Building, Waterloo Campus, United Kingdom (F.A., D.T., E.C., K.A., J.d.S.V., X.K., B.B., C.A.R., L.G., S.D.B.)
| | - Kate Arkless
- From the Section of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Excellence, King's College London, Franklin-Wilkins Building, Waterloo Campus, United Kingdom (F.A., D.T., E.C., K.A., J.d.S.V., X.K., B.B., C.A.R., L.G., S.D.B.)
| | - Erica Ruth Hendrikse
- From the Section of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Excellence, King's College London, Franklin-Wilkins Building, Waterloo Campus, United Kingdom (F.A., D.T., E.C., K.A., J.d.S.V., X.K., B.B., C.A.R., L.G., S.D.B.)
| | - Joao de Sousa Valente
- From the Section of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Excellence, King's College London, Franklin-Wilkins Building, Waterloo Campus, United Kingdom (F.A., D.T., E.C., K.A., J.d.S.V., X.K., B.B., C.A.R., L.G., S.D.B.)
| | - Xenia Kodji
- From the Section of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Excellence, King's College London, Franklin-Wilkins Building, Waterloo Campus, United Kingdom (F.A., D.T., E.C., K.A., J.d.S.V., X.K., B.B., C.A.R., L.G., S.D.B.)
| | - Brentton Barrett
- From the Section of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Excellence, King's College London, Franklin-Wilkins Building, Waterloo Campus, United Kingdom (F.A., D.T., E.C., K.A., J.d.S.V., X.K., B.B., C.A.R., L.G., S.D.B.)
| | - Carlo Alberto Ricciardi
- From the Section of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Excellence, King's College London, Franklin-Wilkins Building, Waterloo Campus, United Kingdom (F.A., D.T., E.C., K.A., J.d.S.V., X.K., B.B., C.A.R., L.G., S.D.B.)
| | - Luigi Gnudi
- From the Section of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Excellence, King's College London, Franklin-Wilkins Building, Waterloo Campus, United Kingdom (F.A., D.T., E.C., K.A., J.d.S.V., X.K., B.B., C.A.R., L.G., S.D.B.)
| | - Debbie Lucy Hay
- School of Biological Sciences, University of Auckland, New Zealand (D.L.H.)
| | - Susan Diana Brain
- From the Section of Vascular Biology and Inflammation, School of Cardiovascular Medicine and Sciences, BHF Cardiovascular Centre of Excellence, King's College London, Franklin-Wilkins Building, Waterloo Campus, United Kingdom (F.A., D.T., E.C., K.A., J.d.S.V., X.K., B.B., C.A.R., L.G., S.D.B.)
| |
Collapse
|
2
|
Fish M, Arkless K, Jennings A, Wilson J, Carter MJ, Arbane G, Campos S, Novellas N, Wester R, Petrov N, Niazi U, Sanderson B, Ellis R, Saqi M, Spencer J, Singer M, Martinez-Nunez RT, Pitchford S, Swanson CM, Shankar-Hari M. Cellular and molecular mechanisms of IMMunE dysfunction and Recovery from SEpsis-related critical illness in adults: An observational cohort study (IMMERSE) protocol paper. J Intensive Care Soc 2020; 23:318-324. [DOI: 10.1177/1751143720966286] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
Sepsis is a common illness. Immune responses are considered major drivers of sepsis illness and outcomes. However, there are no proven immunomodulator therapies in sepsis. We hypothesised that in-depth characterisation of sepsis-specific immune trajectory may inform immunomodulation in sepsis-related critical illness. We describe the protocol of the IMMERSE study to address this hypothesis. We include critically ill sepsis patients without documented immune comorbidity and age–sex matched cardiac surgical patients as controls. We plan to perform an in-depth biological characterisation of innate and adaptive immune systems, platelet function, humoral components and transcriptional determinants of the immune system responses in sepsis. This will be done at pre-specified time points during their critical illness to generate an illness trajectory. The sample size for each biological assessment is different and is described in detail. In summary, the overall aim of the IMMERSE study is to increase the granularity of longitudinal immunology model of sepsis to inform future immunomodulation trials.
Collapse
Affiliation(s)
- Matthew Fish
- School of Immunology and Microbial Sciences, Kings College London, London, UK
- Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK
| | - Kate Arkless
- Institute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK
| | - Aislinn Jennings
- School of Immunology and Microbial Sciences, Kings College London, London, UK
- Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK
| | - Julie Wilson
- School of Immunology and Microbial Sciences, Kings College London, London, UK
- Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK
| | - Michael J Carter
- Department of Women and Children’s Health, King’s College London, London, UK
| | - Gill Arbane
- Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK
| | - Sara Campos
- Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK
| | - Neus Novellas
- Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK
| | - Rianne Wester
- NIHR Guy’s and St Thomas’ Biomedical Research Centre at Guy’s and St Thomas NHS Foundation Trust, St Thomas’ Hospital, London, UK
- King’s College London, London, UK
| | - Nedyalko Petrov
- NIHR Guy’s and St Thomas’ Biomedical Research Centre at Guy’s and St Thomas NHS Foundation Trust, St Thomas’ Hospital, London, UK
- King’s College London, London, UK
| | - Umar Niazi
- Faculty of Life Sciences, King’s College London, London, UK
| | - Barney Sanderson
- Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK
| | - Richard Ellis
- NIHR Guy’s and St Thomas’ Biomedical Research Centre at Guy’s and St Thomas NHS Foundation Trust, St Thomas’ Hospital, London, UK
- King’s College London, London, UK
| | - Mansoor Saqi
- Faculty of Life Sciences, King’s College London, London, UK
| | - Jo Spencer
- School of Immunology and Microbial Sciences, Kings College London, London, UK
| | - Mervyn Singer
- Bloomsbury Institute of Intensive Care Medicine, UCL, London, UK
| | | | - Simon Pitchford
- Institute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK
| | - Chad M Swanson
- School of Immunology and Microbial Sciences, Kings College London, London, UK
| | - Manu Shankar-Hari
- School of Immunology and Microbial Sciences, Kings College London, London, UK
- Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK
| |
Collapse
|
3
|
Pitchford S, Cleary S, Arkless K, Amison R. Pharmacological strategies for targeting platelet activation in asthma. Curr Opin Pharmacol 2019; 46:55-64. [PMID: 31026626 DOI: 10.1016/j.coph.2019.03.012] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2019] [Revised: 03/18/2019] [Accepted: 03/22/2019] [Indexed: 12/22/2022]
Abstract
The activation of platelets during host defence and inflammatory disorders has become increasingly documented. Clinical studies of patients with asthma reveal heightened platelet activation and accumulation into lung tissue. Accompanying studies in animal models of allergic lung inflammation, using protocols of experimentally induced thrombocytopenia proclaim an important role for platelets during the leukocyte recruitment cascade, tissue integrity, and lung function. The functions of platelets during these inflammatory events are clearly distinct to platelet functions during haemostasis and clot formation, and have led to the concept that a dichotomy (or polytomy, depending on what else platelets do) in platelet activation exists. The platelet, therefore, presents us with novel opportunities for modulating these inflammatory responses. This review discusses the rationale and effectiveness of current anti-platelet drugs in their use to supress inflammation with regard to asthma, and the need to consider novel possibilities for pharmacological modulation of platelet function associated with inflammation that are pharmacologically distinct to current anti-platelet therapies.
Collapse
Affiliation(s)
- Simon Pitchford
- Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, UK.
| | - Simon Cleary
- University of California San Francisco (UCSF), Department of Medicine, San Francisco, USA
| | - Kate Arkless
- Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, UK
| | - Richard Amison
- Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, UK
| |
Collapse
|
4
|
Arkless K, Argunhan F, Brain SD. CGRP Discovery and Timeline. Handb Exp Pharmacol 2019; 255:1-12. [PMID: 30430259 DOI: 10.1007/164_2018_129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Calcitonin gene-related peptide (CGRP) was discovered over about 35 years ago through molecular biological techniques. Its activity as a vasodilator and the proposal that it was involved in pain processing were then soon established. Today, we are in the interesting situation of having the approval for the clinical use of antagonists and antibodies that have proved to block CGRP activities and benefit migraine. Despite all, there is still much to learn concerning the relevance of the vasodilator and other activities as well as further potential applications of CGRP agonists and blockers in disease. This review aims to discuss the history and present knowledge and to act as an introductory chapter in this volume.
Collapse
Affiliation(s)
- Kate Arkless
- Section of Vascular Biology & Inflammation, School of Cardiovascular Medicine & Sciences, BHF Centre for Cardiovascular Sciences, King's College London, London, UK
| | - Fulye Argunhan
- Section of Vascular Biology & Inflammation, School of Cardiovascular Medicine & Sciences, BHF Centre for Cardiovascular Sciences, King's College London, London, UK
| | - Susan D Brain
- Section of Vascular Biology & Inflammation, School of Cardiovascular Medicine & Sciences, BHF Centre for Cardiovascular Sciences, King's College London, London, UK.
| |
Collapse
|